A Study to Investigate Efficacy, Safety, Pharmacodynamics and Pharmacokinetics of ASP6294 in the Treatment of Female Subjects With Bladder Pain Syndrome/Interstitial Cystitis

NCT03282318 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

119

Enrollment

INDUSTRY

Sponsor class

Conditions

Bladder Pain Syndrome
Interstitial Cystitis

Interventions

DRUG: ASP6294
DRUG: Placebo

Sponsor

Astellas Pharma Europe B.V.